Previous Close | 19.97 |
Open | 19.79 |
Bid | 21.14 x 1000 |
Ask | 21.89 x 800 |
Day's Range | 18.96 - 19.96 |
52 Week Range | 16.51 - 59.99 |
Volume | |
Avg. Volume | 952,930 |
Market Cap | 1.164B |
Beta (5Y Monthly) | 0.87 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -9.05 |
Earnings Date | Apr 30, 2024 - May 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 27.50 |
Subscribe to Yahoo Finance Plus to view Fair Value for SAGE
In this article, we will be taking a look at the 25 most stressed cities in the United States. If you do not want to learn about the global impact of stress and depression, head straight to the 5 Most Stressed Cities in the United States. In the bustling landscape of the United States, certain […]
Sage Therapeutics, Inc. (SAGE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CAMBRIDGE, Mass., February 28, 2024--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the following upcoming investor conferences in March: